Sign up to save your podcasts
Or
Share Morgan Stanley Reports Strong Results As Dealmaking Strengthens
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Morgan Stanley Reports Strong Results As Dealmaking Strengthens
Plus: Novavax says the FDA rejected its combination Covid-19 and flu vaccine because of a “serious adverse event” in a clinical-trial participant. Elon Musk’s SpaceX sues California regulators for voting down a request to allow more of the company’s rocket launches there. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By The Wall Street Journal
4.2
623623 ratings
Plus: Novavax says the FDA rejected its combination Covid-19 and flu vaccine because of a “serious adverse event” in a clinical-trial participant. Elon Musk’s SpaceX sues California regulators for voting down a request to allow more of the company’s rocket launches there. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like WSJ Minute Briefing
View all
WSJ Tech News Briefing
1,632 Listeners
WSJ What’s News
4,316 Listeners
WSJ Your Money Briefing
1,751 Listeners
Bloomberg Intelligence
402 Listeners
Bloomberg Businessweek
443 Listeners
WSJ Opinion: Potomac Watch
2,792 Listeners
Bold Names
1,442 Listeners
Wall Street Breakfast
1,005 Listeners
Thoughts on the Market
1,280 Listeners
The Journal.
5,907 Listeners
Barron's Streetwise
1,522 Listeners
Barron's Live
189 Listeners
Bad Bets
1,317 Listeners
WSJ Opinion: Free Expression
570 Listeners
As We Work
151 Listeners
Bloomberg Daybreak: US Edition
49 Listeners
Goldman Sachs The Markets
74 Listeners
WSJ's Take On the Week
124 Listeners